Emergence of Resistant Clones in Medullary Thyroid Cancer May Not Be Rescued by Subsequent Salvage Highly Selective Rearranged During Transfection-Inhibitor Therapy
Overview
Affiliations
DLK1 Is Associated with Stemness Phenotype in Medullary Thyroid Carcinoma Cell Lines.
da Silva D, Araldi R, Belizario M, Rocha W, Monteiro de Barros Maciel R, Cerutti J Int J Mol Sci. 2024; 25(22).
PMID: 39595993 PMC: 11594232. DOI: 10.3390/ijms252211924.
Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the .
Sahakian N, Castinetti F, Romanet P Cancers (Basel). 2023; 15(19).
PMID: 37835559 PMC: 10572078. DOI: 10.3390/cancers15194865.
Management of Progressive Radioiodine-Refractory Thyroid Carcinoma: Current Perspective.
Nervo A, Retta F, Ragni A, Piovesan A, Gallo M, Arvat E Cancer Manag Res. 2022; 14:3047-3062.
PMID: 36275786 PMC: 9584766. DOI: 10.2147/CMAR.S340967.
Predictive Biomarkers in Thyroid Cancer.
Macerola E, Poma A, Vignali P, Proietti A, Ugolini C, Torregrossa L Front Oncol. 2022; 12:901004.
PMID: 35600349 PMC: 9120826. DOI: 10.3389/fonc.2022.901004.
Precision therapy for RET-altered cancers with RET inhibitors.
Thein K, Velcheti V, Mooers B, Wu J, Subbiah V Trends Cancer. 2021; 7(12):1074-1088.
PMID: 34391699 PMC: 8599646. DOI: 10.1016/j.trecan.2021.07.003.